BioGaia AB (publ) (STO:BIOG.B)
Sweden · Delayed Price · Currency is SEK 95.45
-3.05 (-3.10%)
Aug 1, 2025, 5:29 PM CET
Revance Therapeutics Market Cap
BioGaia AB has a market cap or net worth of 9.66 billion as of August 1, 2025. Its market cap has decreased by -22.57% in one year.
Market Cap
9.66B
Enterprise Value
9.03B
Revenue
1.44B
Ranking
n/a
PE Ratio
33.72
Stock Price
$95.45
Market Cap Chart
Since December 31, 1998, BioGaia AB's market cap has increased from 181.00M to 9.66B, an increase of 5,234.71%. That is a compound annual growth rate of 16.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 9.96B | -11.97% |
| Dec 30, 2024 | 11.32B | 10.77% |
| Dec 29, 2023 | 10.22B | 21.10% |
| Dec 30, 2022 | 8.44B | -19.33% |
| Dec 30, 2021 | 10.46B | -3.54% |
| Dec 30, 2020 | 10.85B | 47.37% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 96.35B |
| Sectra AB | 71.68B |
| Getinge AB | 53.34B |
| Camurus AB | 41.80B |
| Medicover AB | 41.67B |
| Asker Healthcare Group AB | 38.24B |
| Bonesupport Holding AB | 22.17B |
| AddLife AB | 21.05B |